Medium-sized drug makers go for duel with multinational giant

Published: 2006-08-09 06:59:00

Updated: 2006-08-09 06:59:00

Competition is about to heat up in the Korean antihypertensive market dominated by Pfizer Korea's Norvasc (amlodipine besylate) as a growing number of medium-sized pharmaceutical firms are ready to enter the local market.

Hanlim Pharm announced on August 7 that it would step into the antihyper...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK